Lobachevsky University takes part in the 3rd General Assembly of the EPTRI project
On March 27-28, Vice-Rector for Research Viktor Kazantsev and Director of the International Affairs Department Irina Leonova represented Lobachevsky University at the meeting of the Consortium for Biological and Pharmacological Research (CVBF). The Consortium is the coordinator of the government-supported project EPTRI (European Pediatric Translational Research Infrastructure). On the first day of the meeting, consortium members summed up the results of the project’s first year and discussed the format of further work, as well as financial and research opportunities of the project participants.
During a specialized workshop with the Young Persons Advisory Group, meeting participants discussed the importance of building a research infrastructure that will be targeted specifically at patients, in particular, children and their families. At the round table, broader issues were raised, including a wider participation of EPTRI at the global level in order to support research in the field of pediatrics. At this session, Viktor Kazantsev made a presentation on the results on Lobachevsky University’s work and on the prospects for its development. Irina Leonova acted as moderator at the session that discussed the issues of project coordination and its results.
On the second day of the Assembly, the focus was on the problems of maintaining the achieved results and assessing the tasks set for the future. A model for further work on the project was presented to the participants, taking into account the strategic role of each member of the Consortium. A plan of activities was also presented for the next stage of the project, which will be implemented along with the work on the proposal to include EPTRI in the roadmap of the European Strategic Forum on Research Infrastructure 2020 (ESFRI).
EPTRI (European Pediatric Translational Research Infrastructure) project, coordinated by the Consortium for Biological and Pharmacological Research (CVBF), aims to create the basis for a new research infrastructure for the development of medicines for children, subsequent clinical research and the use of medicines in pediatrics . This project is carried out in the framework of the European program "HORIZON 2020".